REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Lix Mar Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Lix Mar Sas Profile Updated: February 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorios Lix Mar Sas is an enterprise based in Colombia. Its main office is in Bogota D.C.. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on August 23, 1985. The total number of employees is currently 9 (2024). There was a net sales revenue increase of 30.07% reported in Laboratorios Lix Mar Sas’s latest financial highlights for 2023. There was a total growth of 23.23% in Laboratorios Lix Mar Sas’s total assets over the same period. In 2023, Laboratorios Lix Mar Sas’s net profit margin decreased by 8.57%.

Headquarters
Ac 63 # 70 D 50
Bogota D.C.; Bogota D.C; Postal Code: 0907

Contact Details: Purchase the Laboratorios Lix Mar Sas report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Lix Mar Sas report to view the information.
Outstanding Shares:
Purchase the Laboratorios Lix Mar Sas report to view the information.
Incorporation Date:
August 23, 1985
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Company Performance
Financial values in the chart are available after Laboratorios Lix Mar Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
30.07%
Total operating revenue
30.07%
Operating profit (EBIT)
-46.17%
Net Profit (Loss) for the Period
-43.69%
Total assets
23.23%
Total equity
69.76%
Operating Profit Margin (ROS)
-9.1%
Net Profit Margin
-8.57%
Return on Equity (ROE)
-17.37%
Quick Ratio
2.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?